查看购物车
  • Traditional Chinese
  • English
  • Japanese
全球呼吸照护设备市场（按产品、适应症、最终用户和地区划分）- 预测至 2030 年
市场调查报告书
商品编码
1771770

全球呼吸照护设备市场（按产品、适应症、最终用户和地区划分）- 预测至 2030 年

Respiratory Care Devices Market by Product, Disease Indication, End User - Global Forecast to 2030
出版日期: | 出版商: MarketsandMarkets | 英文 475 Pages | 订单完成后即时交付

价格

全球呼吸照护设备市场规模预计将从 2025 年的 236 亿美元成长到 2030 年的 336 亿美元，预测期内的复合年增长率为 7.3%。

研究范围
调查年份 2024-2030
基准年 2024
预测期 2024-2030
对价单位 金额（十亿美元）
部分 按产品、按适应症、按最终用户、按地区
目标区域 北美、欧洲、亚太地区、中东和非洲、拉丁美洲

各种人口、医疗和环境因素共同推动了呼吸照护设备市场的成长，其中之一就是全球呼吸系统疾病发生率的上升。气喘、睡眠呼吸中止症和慢性阻塞性肺病(COPD) 等呼吸系统疾病是典型的呼吸系统疾病，主要原因是吸烟、老龄化和空气污染加剧。在新冠疫情期间，人们在人工呼吸器、氧气疗法和监测设备上投入了大量资金，同时人们对呼吸支持的认识也提高了。

治疗设备在大多数急性和慢性呼吸系统疾病的治疗和管理中至关重要。它们用于为患有慢性阻塞性肺病 (COPD)、气喘、睡眠呼吸中止症和呼吸功能不全的患者提供维持生命的呼吸治疗。这些设备包括高流量氧气鼻管系统、持续性正压呼吸器 (CPAP) 和双水平气道正压通气 (BiPAP) 机器、雾化器、人工呼吸器、氧气浓缩机机等。由于长期居家呼吸治疗的需求、全球慢性病负担和住院治疗的增加，治疗设备市场规模已扩大数倍。

呼吸照护设备慢性阻塞性肺病(COPD) 是一种全球性、发病率不断上升的疾病，尤其在老年人群体中。这归因于对非侵入性人工呼吸器、氧气浓缩机、雾化器和监视器的需求不断增长。 COPD 是一种进行性、不可逆的疾病，需要持续警觉和长期呼吸治疗。吸烟、空气污染和职业暴露等高危险因子在开发中国家国家和已开发国家都很普遍，也是 COPD 的诱因。 COPD 与住院和病情加重有关，因此需要在家中和医院反覆使用呼吸设备。

受人口老化、吸烟史延长和肥胖率上升的影响，北美地区气喘、睡眠呼吸中止症和慢性阻塞性肺病 (COPD) 等慢性呼吸系统疾病的发生率正在上升。该地区拥有完善的医疗保健体系，人们日益意识到呼吸系统健康的重要性，这使得这些疾病能够及早发现和治疗。新冠疫情 (COVID-19) 疫情刺激了人工呼吸器和氧气疗法设备的需求。医疗设备製造商改进了报销政策。整合远端医疗和远端监控的呼吸设备等创新技术的快速普及，正在推动这一市场的形成。

本报告研究了全球呼吸护理设备市场，提供了按产品、适应症、最终用户和地理趋势分類的市场详细信息，以及参与市场的公司概况。

目录

第一章 引言

第二章调查方法

第三章执行摘要

第四章重要考察

第五章市场概述

  • 介绍
  • 市场动态
  • 监管状况
  • 法规结构
  • 技术分析
  • 产业趋势
  • 价值链分析
  • 供应链分析
  • 贸易分析
  • 定价分析
  • 赎回方案
  • 波特五力分析
  • 邻近市场分析
  • 专利分析
  • 生态系覆盖率
  • 大型会议及活动（2025-2026）
  • 2025-2026 年重要会议与活动
  • 案例研究
  • 影响客户业务的趋势/中断
  • 主要相关人员和采购标准
  • 主要购买标准
  • 投资/创业投资
  • 呼吸护理设备市场中未满足的需求/最终用户期望
  • 人工智慧（AI）对呼吸护理设备市场的影响
  • 2025年美国关税的影响—概述
  • 主要关税税率
  • 价格影响分析
  • 对最终用户产业的影响

6. 呼吸护理设备市场（依产品）

  • 介绍
  • 治疗性呼吸照护设备
  • 监控设备
  • 诊断呼吸护理设备
  • 耗材及配件

第七章呼吸照护设备市场（按适应症）

  • 介绍
  • 慢性阻塞性肺病（COPD）
  • 睡眠呼吸中止症
  • 气喘
  • 感染疾病
  • 其他的

8. 呼吸照护设备市场（依最终用户划分）

  • 介绍
  • 医院
  • 居家照护
  • 门诊护理中心（ACCS）
  • 其他的

9. 呼吸照护设备市场（按地区）

  • 介绍
  • 北美洲
    • 北美宏观经济展望
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲宏观经济展望
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 其他的
  • 亚太地区
    • 亚太宏观经济展望
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 其他的
  • 拉丁美洲
    • 拉丁美洲宏观经济展望
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 中东和非洲宏观经济展望
    • 海湾合作委员会国家
    • 其他的

第十章 竞争格局

  • 概述
  • 主要参与企业的策略/优势
  • 收益分析
  • 市场占有率分析
  • 公司估值矩阵：2024 年主要参与企业
  • 公司估值矩阵：Start-Ups/中小企业，2023 年
  • 估值和财务指标
  • 品牌/产品比较
  • 竞争场景

第十一章 公司简介

  • 主要参与企业
    • KONINKLIJKE PHILIPS NV
    • MEDTRONIC
    • RESMED INC.
    • FISHER & PAYKEL HEALTHCARE LIMITED
    • DRAGERWERK AG & CO. KGAA
    • MASIMO
    • GETINGE
    • NIHON KOHDEN CORPORATION
    • GE HEALTHCARE
    • HILLROM & WELCH ALLYN（BAXTER INTERNATIONAL, INC）
    • ADAPTHEALTH, LLC
    • TELEFLEX INCORPORATED
    • AIR LIQUIDE
    • ICU MEDICAL, INC.
    • HAMILTON MEDICAL
  • 其他公司
    • MEDLINE INDUSTRIES, LP
    • ALLIED MEDICAL LLC
    • NONIN
    • APEX MEDICAL
    • ROTECH HEALTHCARE, INC.
    • LOWENSTEIN MEDICAL SE & CO. KG
    • WEINMANN EMERGENCY MEDICAL TECHNOLOGY GMBH+CO. KG
    • DRIVE DEVILBISS HEALTHCARE
    • OMRON HEALTHCARE, INC.
    • HUM GMBH

第十二章 附录

Product Code: MD 1583

The global respiratory care devices market is projected to reach USD 33.6 billion by 2030 from USD 23.6 billion in 2025, at a CAGR of 7.3% during the forecast period.

Scope of the Report
Years Considered for the Study2024-2030
Base Year2024
Forecast Period2024-2030
Units ConsideredValue (USD billion)
SegmentsProduct Type, Disease Indication, End User, and Region
Regions coveredNorth America, Europe, Asia Pacific, Middle East & Africa, and Latin America

Various demographic, medical, and environmental determinants form a package fueling market growth in respiratory care equipment. One of them is the increase in the global incidence of respiratory disease. Respiratory diseases such as asthma, sleep apnea, and chronic obstructive pulmonary disease (COPD) are typical examples of respiratory disease, largely because of smoking, aging, and increasingly increasing levels of air pollution. Respiratory support awareness increased with mass deployment of spending on ventilators, oxygen therapy, and monitoring devices during the COVID-19 period.

By product type, the therapeutic devices segment is expected to have the largest market share in the respiratory care devices market.

Therapeutic devices are essential in the treatment and management of most acute and chronic respiratory diseases. They are employed to provide life-supporting respiratory therapy to COPD, asthma, sleep apnea, and respiratory failure patients. The devices include high-flow nasal cannula systems, CPAP and BiPAP devices, nebulizers, ventilators, and oxygen concentrators. The therapeutic equipment market has expanded multi-fold due to the need for long-term home respiratory therapy, the global burden of chronic disease, and hospitalization.

By disease indication, the COPD segment is expected to have the largest market share in the respiratory care devices market.

The respiratory care equipment is dominated by Chronic Obstructive Pulmonary Disease (COPD), which is increasingly a global disease, especially in the geriatric population. This is because of the higher demand for non-invasive ventilators, oxygen concentrators, nebulizers, and monitors. Since COPD is a progressive and irreversible disease, constant attention and long-term respiratory treatment are required for the same. The disease is also caused by high-risk factors prevalent in developing and industrialized societies, including smoking, air pollution, and occupational exposures. Since COPD is hospitalized and has exacerbations, repeated use of respiratory equipment in the home and hospital setting is necessitated.

North America is expected to have the largest market share in the respiratory care devices market.

In North America, the increasing prevalence of chronic respiratory conditions such as asthma, sleep apnea, and COPD can be attributed to an aging population, a long history of smoking, and the growing rates of obesity. The region has a robust healthcare system and a growing awareness of the importance of respiratory health, which allows for early detection and treatment of these conditions. The COVID-19 pandemic boosted the demand for ventilators and oxygen therapy equipment. Medical device manufacturers improved reimbursement policies. There has been a rapid adoption of innovative technologies such as respiratory devices that integrate telehealth and remote monitoring have all played a role in shaping this market.

A breakdown of the primary participants (supply-side) for the respiratory care devices market referred to in this report is provided below:

  • By Company Type: Tier 1: 35%, Tier 2: 40%, and Tier 3: 25%
  • By Designation: C-level: 45%, Director Level: 35%, and Others: 20%
  • By Region: North America: 27%, Europe: 25%, Asia Pacific: 30%, Latin America: 8%, Middle East & Africa: 10%

Prominent players in the respiratory care devices market are Koninklijke Philips N.V. (Netherlands), Medtronic (Ireland), ResMed Inc. (US), Fisher & Paykel Healthcare Limited (New Zealand), and Dragerwerk AG & Co. KGaA (Germany).

Research Coverage

The report analyzes the respiratory care devices market and aims to estimate the market size and future growth potential of this market based on various segments such as product type, application, end user, and region. The report also includes a competitive analysis of the key players in this market, along with their company profiles, service offerings, recent developments, and key market strategies.

Reasons to Buy the Report

The report will help the market leaders/new entrants by providing information on the closest approximations of the revenue numbers for the overall respiratory care devices market. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report provides insights into the following pointers:

  • Analysis of key drivers (increasing prevalence of respiratory diseases, surge in preterm births, Growing outbreaks of infectious diseases affecting respiratory system, rising issue of sleep disorders, increasing focus on improved patient outcomes, rising R&D investments for medical devices), restraints (unfavorable reimbursement scenario, availability of low-cost products from local manufacturers, high cost of continuous positive airway pressure machines), opportunities (growing demand for home care therapeutic devices, Opportunities in emerging markets, increasing preference for self-testing, growing awareness about ill effects of untreated sleep apnea) and challenges (low awareness and lack of diagnosis of respiratory diseases, harmful effects of respiratory care devices on neonates, lack of patient compliance with CPAP therapy)
  • Market Penetration: It includes extensive information on products offered by the major players in the global respiratory care devices market. The report includes various segments in product type, disease indication, end user, and region.
  • Product Enhancement/Innovation: Comprehensive details about product launches and anticipated trends in the global respiratory care devices market
  • Market Development: Thorough knowledge and analysis of the profitable rising markets by type, disease indication, end user, and region.
  • Market Diversification: Comprehensive information about newly launched products, expanding markets, current advancements, and investments in the global respiratory care devices market
  • Competitive Assessment: Thorough evaluation of the market shares, growth plans, offerings of products, and capacities of the major competitors in the global respiratory care devices market.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS AND EXCLUSIONS
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
    • 1.3.2 YEARS CONSIDERED
  • 1.4 CURRENCY CONSIDERED
  • 1.5 STAKEHOLDERS
  • 1.6 LIMITATIONS
  • 1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Key data from primary sources
      • 2.1.2.2 Key industry insights
  • 2.2 MARKET SIZE ESTIMATION
  • 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.4 ASSUMPTIONS
    • 2.4.1 MARKET SHARE ASSUMPTIONS
    • 2.4.2 RESEARCH ASSUMPTIONS
  • 2.5 RISK ASSESSMENT
  • 2.6 METHODOLOGY-RELATED LIMITATIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 RESPIRATORY CARE DEVICES MARKET OVERVIEW
  • 4.2 ASIA PACIFIC: RESPIRATORY CARE DEVICES MARKET, 2024
  • 4.3 RESPIRATORY CARE DEVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
  • 4.4 RESPIRATORY CARE DEVICES MARKET: GEOGRAPHIC MIX
  • 4.5 RESPIRATORY CARE DEVICES MARKET: DEVELOPING VS. DEVELOPED MARKETS

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Rising prevalence of respiratory diseases
        • 5.2.1.1.1 Rapid growth in global geriatric population
        • 5.2.1.1.2 Urbanization and growing pollution levels
        • 5.2.1.1.3 Growing tobacco consumption
        • 5.2.1.1.4 Increased adoption of sedentary lifestyles
      • 5.2.1.2 Surging incidence rate of preterm births
      • 5.2.1.3 Growing outbreaks of infectious diseases affecting respiratory systems
      • 5.2.1.4 Rising population with sleep disorders
      • 5.2.1.5 Improved patient outcomes using respiratory care devices
      • 5.2.1.6 Rising R&D investments for technological advancement of medical devices
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Unfavorable reimbursement scenario for respiratory care diagnostics
      • 5.2.2.2 Availability of low-cost products from local manufacturers
      • 5.2.2.3 High cost of CPAP machines
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Growing demand for home care therapeutic devices
      • 5.2.3.2 Market growth opportunities in Asia Pacific
      • 5.2.3.3 Increasing preference for self-testing
      • 5.2.3.4 Growing awareness about ill effects of untreated sleep apnea
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Low awareness and lack of diagnosis of respiratory diseases
      • 5.2.4.2 Harmful effects of certain respiratory care devices on neonates
      • 5.2.4.3 Lack of patient compliance with CPAP therapy
  • 5.3 REGULATORY LANDSCAPE
  • 5.4 REGULATORY FRAMEWORK
    • 5.4.1 NORTH AMERICA
      • 5.4.1.1 US
      • 5.4.1.2 Canada
    • 5.4.2 EUROPE
    • 5.4.3 ASIA PACIFIC
      • 5.4.3.1 Japan
      • 5.4.3.2 China
      • 5.4.3.3 India
    • 5.4.4 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.5 TECHNOLOGY ANALYSIS
    • 5.5.1 KEY TECHNOLOGIES
      • 5.5.1.1 OXYGEN THERAPY SYSTEMS
      • 5.5.1.2 AIRWAY MANAGEMENT DEVICES
      • 5.5.1.3 PULMONARY FUNCTION TESTING (PFT) DEVICES
      • 5.5.1.4 MONITORING SENSORS
    • 5.5.2 COMPLEMENTARY TECHNOLOGIES
      • 5.5.2.1 TELEMEDICINE PLATFORMS
      • 5.5.2.2 MOBILE HEALTH (MHEALTH) APPS
      • 5.5.2.3 WEARABLE RESPIRATORY TRACKERS
    • 5.5.3 ADJACENT TECHNOLOGIES
      • 5.5.3.1 SMART INHALERS
      • 5.5.3.2 ENVIRONMENTAL SENSING DEVICES
  • 5.6 INDUSTRY TRENDS
    • 5.6.1 MINIATURIZATION AND PORTABILITY
    • 5.6.2 SMART CONNECTIVITY AND IOT (INTERNET OF THINGS) INTEGRATION
    • 5.6.3 GROWING DEMAND FOR MULTIMODAL VENTILATION
    • 5.6.4 RISING ADOPTION OF NON-INVASIVE VENTILATION
    • 5.6.5 PERSONALIZED TREATMENT SOLUTIONS
  • 5.7 VALUE CHAIN ANALYSIS
  • 5.8 SUPPLY CHAIN ANALYSIS
  • 5.9 TRADE ANALYSIS
    • 5.9.1 TRADE ANALYSIS FOR RESPIRATORY CARE DEVICES PRODUCTS
  • 5.10 PRICING ANALYSIS
    • 5.10.1 AVERAGE SELLING PRICE OF RESPIRATORY CARE DEVICES, BY KEY PLAYER, 2024 (USD)
    • 5.10.2 AVERAGE SELLING PRICE OF RESPIRATORY CARE DEVICES, BY REGION, 2024 (USD)
  • 5.11 REIMBURSEMENT SCENARIO
  • 5.12 PORTER'S FIVE FORCES ANALYSIS
    • 5.12.1 THREAT OF NEW ENTRANTS
    • 5.12.2 THREAT OF SUBSTITUTES
    • 5.12.3 BARGAINING POWER OF SUPPLIERS
    • 5.12.4 BARGAINING POWER OF BUYERS
    • 5.12.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.13 ADJACENT MARKET ANALYSIS
  • 5.14 PATENT ANALYSIS
  • 5.15 ECOSYSTEM COVERAGE
  • 5.16 KEY CONFERENCES AND EVENTS (2025-2026)
  • 5.17 KEY CONFERENCES & EVENTS DURING 2025-2026
  • 5.18 CASE STUDIES
  • 5.19 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • 5.20 KEY STAKEHOLDERS & BUYING CRITERIA
    • 5.20.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 5.21 KEY BUYING CRITERIA
  • 5.22 INVESTMENT/VENTURE CAPITAL
  • 5.23 UNMET NEEDS/END-USER EXPECTATIONS IN RESPIRATORY CARE DEVICES MARKET
  • 5.24 IMPACT OF ARTIFICIAL INTELLIGENCE (AI) ON RESPIRATORY CARE DEVICES MARKET
  • 5.25 IMPACT OF 2025 US TARIFF - OVERVIEW
    • 5.25.1 INTRODUCTION
  • 5.26 KEY TARIFF RATES
  • 5.27 PRICE IMPACT ANALYSIS
    • 5.27.1 IMPACT ON COUNTRY/REGION
      • 5.27.1.1 US
      • 5.27.1.2 Europe
      • 5.27.1.3 Asia Pacific
  • 5.28 IMPACT ON END-USER INDUSTRIES

6 RESPIRATORY CARE DEVICES MARKET, BY PRODUCT

  • 6.1 INTRODUCTION
  • 6.2 THERAPEUTIC RESPIRATORY CARE DEVICES
    • 6.2.1 PAP DEVICES
      • 6.2.1.1 CPAP devices
        • 6.2.1.1.1 Growing popularity of nasal CPAP therapies to drive demand
      • 6.2.1.2 APAP devices
        • 6.2.1.2.1 Rising awareness among sleep specialists and patients regarding additional features of APAP devices to boost market
      • 6.2.1.3 BiPAP devices
        • 6.2.1.3.1 Increasing number of hospitals to strengthen market
    • 6.2.2 VENTILATORS
      • 6.2.2.1 ICU ventilators
        • 6.2.2.1.1 High-end ventilators
          • 6.2.2.1.1.1 Improving healthcare infrastructure and rising healthcare expenditure to drive market
        • 6.2.2.1.2 Mid-end ventilators
          • 6.2.2.1.2.1 Better affordability and accessibility of mid-end ventilators than high-end models to support market growth
        • 6.2.2.1.3 Basic ventilators
          • 6.2.2.1.3.1 Expanding access to critical healthcare facilities in developing countries to spur demand
      • 6.2.2.2 Portable/Transportable ventilators
        • 6.2.2.2.1 Increasing demand for home care to boost segmental growth
    • 6.2.3 NEBULIZERS
      • 6.2.3.1 Jet nebulizers
        • 6.2.3.1.1 Increasing prevalence of respiratory conditions to augment market
      • 6.2.3.2 Mesh nebulizers
        • 6.2.3.2.1 Deployment of advanced aerosolization technology to drive market
      • 6.2.3.3 Ultrasonic nebulizers
        • 6.2.3.3.1 Adjustable settings for particle size and treatment duration to boost market
    • 6.2.4 HUMIDIFIERS
      • 6.2.4.1 Heated humidifiers
        • 6.2.4.1.1 Ease of control and customizability to fuel market
      • 6.2.4.2 Passover humidifiers
        • 6.2.4.2.1 Minimal maintenance and simple technology to spur demand
    • 6.2.5 OXYGEN CONCENTRATORS
      • 6.2.5.1 Fixed oxygen concentrators
        • 6.2.5.1.1 Better access to healthcare services to spur demand
      • 6.2.5.2 Portable oxygen concentrators
        • 6.2.5.2.1 Low weight and easy setup to drive segmental growth
    • 6.2.6 INHALERS
      • 6.2.6.1 Metered-dose inhalers (MDIs)
        • 6.2.6.1.1 Ongoing advancements in MDI technology to support market growth
      • 6.2.6.2 Dry powder inhalers (DPIs)
        • 6.2.6.2.1 Developments in particle engineering and powder formulations to boost segmental growth
    • 6.2.7 REUSABLE RESUSCITATORS
      • 6.2.7.1 Disposable and reusable nature to drive demand
    • 6.2.8 NITRIC OXIDE DELIVERY UNITS
      • 6.2.8.1 Rising emphasis of companies on developing innovative and advanced nitric oxide delivery units to drive market
    • 6.2.9 OXYGEN HOODS
      • 6.2.9.1 Growing prevalence of respiratory diseases in kids to drive market growth
  • 6.3 MONITORING DEVICES
    • 6.3.1 PULSE OXIMETERS
      • 6.3.1.1 Pulse oximeter sensors
        • 6.3.1.1.1 Development of advanced sensors with embedded chips to boost segmental growth
      • 6.3.1.2 Pulse oximeter equipment
        • 6.3.1.2.1 Growing prevalence of chronic respiratory conditions to boost demand
    • 6.3.2 CAPNOGRAPHS
      • 6.3.2.1 Ongoing R&D on capnographs to offer lucrative growth opportunities
    • 6.3.3 GAS ANALYZERS
      • 6.3.3.1 Increasing demand for point-of-care testing to drive demand
  • 6.4 DIAGNOSTIC RESPIRATORY CARE DEVICES
    • 6.4.1 SPIROMETERS
      • 6.4.1.1 Rising technological advancements in spirometers to support market growth
    • 6.4.2 POLYSOMNOGRAPHY DEVICES (PSG DEVICES)
      • 6.4.2.1 Rising incidence of obstructive sleep apnea to drive demand
    • 6.4.3 PEAK FLOW METERS
      • 6.4.3.1 Low-cost and uncomplicated nature to drive segmental growth
    • 6.4.4 OTHER DIAGNOSTIC DEVICES
  • 6.5 CONSUMABLES & ACCESSORIES
    • 6.5.1 MASKS
      • 6.5.1.1 Reusable masks
        • 6.5.1.1.1 Growing concerns related to air pollution to fuel demand
      • 6.5.1.2 Disposable masks
        • 6.5.1.2.1 Stringent government mandates on wearing masks to spur demand
    • 6.5.2 DISPOSABLE RESUSCITATORS
      • 6.5.2.1 Growing focus on reducing cross-contamination cases in patients to foster segmental growth
    • 6.5.3 TRACHEOSTOMY TUBES
      • 6.5.3.1 Introduction of advanced products with ergonomic designs to drive market growth
    • 6.5.4 BREATHING CIRCUITS
      • 6.5.4.1 Healthcare professionals' efforts to improve infection control practices to drive demand
    • 6.5.5 NASAL CANNULAE
      • 6.5.5.1 Increasing focus on minimally invasive surgery techniques to fuel demand
    • 6.5.6 OTHER CONSUMABLES & ACCESSORIES

7 RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION

  • 7.1 INTRODUCTION
  • 7.2 CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
    • 7.2.1 RISING INDOOR AND OUTDOOR AIR POLLUTION LEVELS TO DRIVE MARKET
  • 7.3 SLEEP APNEA
    • 7.3.1 GROWING INCIDENCE OF OBESITY AND CARDIOVASCULAR DISEASES TO FAVOR MARKET GROWTH
  • 7.4 ASTHMA
    • 7.4.1 INCREASING AIR POLLUTION AND GROWING USE OF TOBACCO-BASED PRODUCTS TO DRIVE MARKET
  • 7.5 INFECTIOUS DISEASES
    • 7.5.1 GROWING NUMBER OF TB PATIENTS TO BOOST MARKET GROWTH
  • 7.6 OTHER DISEASE INDICATIONS

8 RESPIRATORY CARE DEVICES MARKET, BY END USER

  • 8.1 INTRODUCTION
  • 8.2 HOSPITALS
    • 8.2.1 GROWING NUMBER OF HOSPITALS IN EMERGING ECONOMIES TO DRIVE MARKET
  • 8.3 HOME CARE SETTINGS
    • 8.3.1 INCREASING ACCEPTANCE OF HOME CARE DEVICES BY PATIENTS TO BOOST GROWTH
  • 8.4 AMBULATORY CARE CENTERS (ACCS)
    • 8.4.1 IMPROVED PATIENT EXPERIENCE IN AMBULATORY CARE CENTERS TO DRIVE MARKET
  • 8.5 OTHER END USERS

9 RESPIRATORY CARE DEVICES MARKET, BY REGION

  • 9.1 INTRODUCTION
  • 9.2 NORTH AMERICA
    • 9.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    • 9.2.2 US
      • 9.2.2.1 Rapid growth in geriatric population to boost market
    • 9.2.3 CANADA
      • 9.2.3.1 Large pool of undiagnosed patients and vaping trends drive market
  • 9.3 EUROPE
    • 9.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
    • 9.3.2 GERMANY
      • 9.3.2.1 Increasing public healthcare expenditure to foster market growth
    • 9.3.3 FRANCE
      • 9.3.3.1 High prevalence of COPD to surge demand
    • 9.3.4 UK
      • 9.3.4.1 Growing demand for minimally invasive surgeries to drive market
    • 9.3.5 ITALY
      • 9.3.5.1 Growing involvement of private sector in healthcare market to drive market
    • 9.3.6 SPAIN
      • 9.3.6.1 Need to improve healthcare infrastructure due to aging demographic to drive demand
    • 9.3.7 REST OF EUROPE
  • 9.4 ASIA PACIFIC
    • 9.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    • 9.4.2 JAPAN
      • 9.4.2.1 Availability of universal healthcare reimbursement policy to drive market
    • 9.4.3 CHINA
      • 9.4.3.1 Initiatives to modernize healthcare system and reimbursement facilities to support market growth
    • 9.4.4 INDIA
      • 9.4.4.1 Increasing focus of global players on domestic market to drive market
    • 9.4.5 AUSTRALIA
      • 9.4.5.1 High prevalence of chronic lung diseases to drive demand
    • 9.4.6 SOUTH KOREA
      • 9.4.6.1 Expanding geriatric population to fuel market
    • 9.4.7 REST OF ASIA PACIFIC
  • 9.5 LATIN AMERICA
    • 9.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    • 9.5.2 BRAZIL
      • 9.5.2.1 Government initiatives to improve healthcare sector to drive market
    • 9.5.3 MEXICO
      • 9.5.3.1 Rising obesity rate to increase incidence of respiratory diseases
    • 9.5.4 REST OF LATIN AMERICA
  • 9.6 MIDDLE EAST & AFRICA
    • 9.6.1 MACROECONOMIC OUTLOOK FOR MEA
    • 9.6.2 GCC COUNTRIES
      • 9.6.2.1 INCREASING INCIDENCE OF RESPIRATORY DISEASES IN GCC DRIVES MARKET
    • 9.6.3 REST OF MIDDLE EAST & AFRICA

10 COMPETITIVE LANDSCAPE

  • 10.1 OVERVIEW
  • 10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    • 10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN RESPIRATORY CARE DEVICES MARKET
  • 10.3 REVENUE ANALYSIS
  • 10.4 MARKET SHARE ANALYSIS
  • 10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
    • 10.5.1 STARS
    • 10.5.2 EMERGING LEADERS
    • 10.5.3 PERVASIVE PLAYERS
    • 10.5.4 PARTICIPANTS
    • 10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
      • 10.5.5.1 Company footprint
      • 10.5.5.2 Region footprint
      • 10.5.5.3 Product type footprint
      • 10.5.5.4 Disease indication footprint
      • 10.5.5.5 End user footprint
  • 10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
    • 10.6.1 PROGRESSIVE COMPANIES
    • 10.6.2 DYNAMIC COMPANIES
    • 10.6.3 STARTING BLOCKS
    • 10.6.4 RESPONSIVE COMPANIES
    • 10.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
  • 10.7 VALUATION & FINANCIAL METRICS
    • 10.7.1 FINANCIAL METRICS
    • 10.7.2 COMPANY VALUATION
  • 10.8 BRAND/PRODUCT COMPARISON
  • 10.9 COMPETITIVE SCENARIO
    • 10.9.1 PRODUCT & SERVICE LAUNCHES AND APPROVALS
    • 10.9.2 DEALS
    • 10.9.3 EXPANSIONS
    • 10.9.4 OTHER DEVELOPMENTS

11 COMPANY PROFILES

  • 11.1 KEY PLAYERS
    • 11.1.1 KONINKLIJKE PHILIPS N.V.
      • 11.1.1.1 Business overview
      • 11.1.1.2 Products offered
      • 11.1.1.3 Recent developments
        • 11.1.1.3.1 Product launches & approvals
      • 11.1.1.4 MnM view
        • 11.1.1.4.1 Right to win
        • 11.1.1.4.2 Strategic choices
        • 11.1.1.4.3 Weaknesses & competitive threats
    • 11.1.2 MEDTRONIC
      • 11.1.2.1 Business overview
      • 11.1.2.2 Products offered
      • 11.1.2.3 Recent developments
        • 11.1.2.3.1 Product launches & approvals
        • 11.1.2.3.2 Other developments
      • 11.1.2.4 MnM view
        • 11.1.2.4.1 Right to win
        • 11.1.2.4.2 Strategic choices
        • 11.1.2.4.3 Weaknesses & competitive threats
    • 11.1.3 RESMED INC.
      • 11.1.3.1 Business overview
      • 11.1.3.2 Products offered
      • 11.1.3.3 Recent developments
        • 11.1.3.3.1 Product launches & approvals
        • 11.1.3.3.2 Deals
      • 11.1.3.4 MnM view
        • 11.1.3.4.1 Right to win
        • 11.1.3.4.2 Strategic choices
        • 11.1.3.4.3 Weaknesses & competitive threats
    • 11.1.4 FISHER & PAYKEL HEALTHCARE LIMITED
      • 11.1.4.1 Business overview
      • 11.1.4.2 Products offered
      • 11.1.4.3 Recent developments
        • 11.1.4.3.1 Product launches & approvals
      • 11.1.4.4 MnM view
        • 11.1.4.4.1 Right to win
        • 11.1.4.4.2 Strategic choices
        • 11.1.4.4.3 Weaknesses & competitive threats
    • 11.1.5 DRAGERWERK AG & CO. KGAA
      • 11.1.5.1 Business overview
      • 11.1.5.2 Products offered
      • 11.1.5.3 Recent developments
        • 11.1.5.3.1 Product launches & approvals
        • 11.1.5.3.2 Deals
        • 11.1.5.3.3 Other developments
      • 11.1.5.4 MnM view
        • 11.1.5.4.1 Right to win
        • 11.1.5.4.2 Strategic choices
        • 11.1.5.4.3 Weaknesses & competitive threats
    • 11.1.6 MASIMO
      • 11.1.6.1 Business overview
      • 11.1.6.2 Products offered
      • 11.1.6.3 Recent developments
        • 11.1.6.3.1 Product launches & approvals
        • 11.1.6.3.2 Deals
        • 11.1.6.3.3 Other developments
    • 11.1.7 GETINGE
      • 11.1.7.1 Business overview
      • 11.1.7.2 Products offered
      • 11.1.7.3 Recent developments
        • 11.1.7.3.1 Product launches & approvals
        • 11.1.7.3.2 Deals
        • 11.1.7.3.3 Expansions
    • 11.1.8 NIHON KOHDEN CORPORATION
      • 11.1.8.1 Business overview
      • 11.1.8.2 Products offered
      • 11.1.8.3 Recent developments
        • 11.1.8.3.1 Product launches & approvals
        • 11.1.8.3.2 Deals
    • 11.1.9 GE HEALTHCARE
      • 11.1.9.1 Business overview
      • 11.1.9.2 Products offered
      • 11.1.9.3 Recent developments
        • 11.1.9.3.1 Deals
        • 11.1.9.3.2 Other developments
    • 11.1.10 HILLROM & WELCH ALLYN (BAXTER INTERNATIONAL, INC)
      • 11.1.10.1 Business overview
      • 11.1.10.2 Products offered
      • 11.1.10.3 Recent developments
        • 11.1.10.3.1 Product launches & approvals
        • 11.1.10.3.2 Deals
    • 11.1.11 ADAPTHEALTH, LLC
      • 11.1.11.1 Business overview
      • 11.1.11.2 Products offered
    • 11.1.12 TELEFLEX INCORPORATED
      • 11.1.12.1 Business overview
      • 11.1.12.2 Products offered
    • 11.1.13 AIR LIQUIDE
      • 11.1.13.1 Business overview
      • 11.1.13.2 Products offered
      • 11.1.13.3 Recent developments
        • 11.1.13.3.1 Deals
    • 11.1.14 ICU MEDICAL, INC.
      • 11.1.14.1 Business overview
      • 11.1.14.2 Products offered
      • 11.1.14.3 Recent developments
        • 11.1.14.3.1 Product launches & approvals
        • 11.1.14.3.2 Deals
    • 11.1.15 HAMILTON MEDICAL
      • 11.1.15.1 Business overview
      • 11.1.15.2 Products offered
      • 11.1.15.3 Recent developments
        • 11.1.15.3.1 Product launches & approvals
  • 11.2 OTHER PLAYERS
    • 11.2.1 MEDLINE INDUSTRIES, LP
    • 11.2.2 ALLIED MEDICAL LLC
    • 11.2.3 NONIN
    • 11.2.4 APEX MEDICAL
    • 11.2.5 ROTECH HEALTHCARE, INC.
    • 11.2.6 LOWENSTEIN MEDICAL SE & CO. KG
    • 11.2.7 WEINMANN EMERGENCY MEDICAL TECHNOLOGY GMBH + CO. KG
    • 11.2.8 DRIVE DEVILBISS HEALTHCARE
    • 11.2.9 OMRON HEALTHCARE, INC.
    • 11.2.10 HUM GMBH

12 APPENDIX

  • 12.1 DISCUSSION GUIDE
  • 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.3 CUSTOMIZATION OPTIONS
  • 12.4 RELATED REPORTS
  • 12.5 AUTHOR DETAILS

List of Tables

  • TABLE 1 ANNUAL AVERAGE EXCHANGE RATE FOR CURRENCY CONVERSION, 2020-2024
  • TABLE 2 RESEARCH ASSUMPTIONS
  • TABLE 3 RISK ASSESSMENT: RESPIRATORY CARE DEVICES MARKET
  • TABLE 4 REGION-WISE DATA ON LIFESTYLE DISEASES
  • TABLE 5 TOP 10 COUNTRIES WITH HIGHEST RATES OF PRETERM BIRTH PER 100 LIVE BIRTHS
  • TABLE 6 PRODUCT LAUNCHES
  • TABLE 7 INITIATIVES TO PROMOTE AWARENESS ABOUT UNTREATED SLEEP APNEA
  • TABLE 8 US: CLASSIFICATION OF MEDICAL EQUIPMENT
  • TABLE 9 US: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
  • TABLE 10 CANADA: LEVEL OF RISK, TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
  • TABLE 11 EUROPE: LEVEL OF RISK, TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
  • TABLE 12 JAPAN: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
  • TABLE 13 CHINA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
  • TABLE 14 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 15 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 16 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 17 IMPORT DATA FOR RESPIRATORY CARE DEVICES (HS CODE 901920), BY COUNTRY, 2020-2024 (USD THOUSAND)
  • TABLE 18 EXPORT DATA FOR RESPIRATORY CARE DEVICES (HS CODE 901920), BY COUNTRY, 2020-2024 (USD THOUSAND)
  • TABLE 19 RESPIRATORY CARE DEVICES MARKET: REIMBURSEMENT SCENARIO
  • TABLE 20 RESPIRATORY CARE DEVICES MARKET: PORTERS FIVE FORCE ANALYSIS
  • TABLE 21 RESPIRATORY CARE DEVICES MARKET: DETAILED LIST OF CONFERENCES & EVENTS
  • TABLE 22 CASE STUDY 1: LONG-TERM VENTILATION WITH VARIABLE PSV
  • TABLE 23 CASE STUDY 2: OPTIMAL UTILIZATION OF MECHANICAL VENTILATOR AT TERTIARY CARE HOSPITAL DURING COVID-19 PANDEMIC
  • TABLE 24 CASE STUDY 3: CHANGING PATTERNS IN LONG-TERM NON-INVASIVE VENTILATION
  • TABLE 25 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR RESPIRATORY CARE DEVICES
  • TABLE 26 KEY BUYING CRITERIA FOR RESPIRATORY CARE DEVICES
  • TABLE 27 RESPIRATORY CARE DEVICES MARKET: UNMET NEEDS
  • TABLE 28 RESPIRATORY CARE DEVICES MARKET: APPLICATION OF ARTIFICIAL INTELLIGENCE
  • TABLE 29 US-ADJUSTED RECIPROCAL TARIFF RATES
  • TABLE 30 KEY PRODUCT-RELATED TARIFF EFFECTIVE FOR RESPIRATORY CARE DEVICES
  • TABLE 31 RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 32 RESPIRATORY CARE DEVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 33 THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 34 THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 35 PAP DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 36 PAP DEVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 37 PAP DEVICES MARKET, BY REGION, 2023-2030 (THOUSAND UNITS)
  • TABLE 38 MAJOR PLAYERS OFFERING CPAP DEVICES
  • TABLE 39 CPAP DEVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 40 MAJOR PLAYERS OFFERING APAP DEVICES
  • TABLE 41 APAP DEVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 42 MAJOR PLAYERS OFFERING BIPAP DEVICES
  • TABLE 43 BIPAP DEVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 44 VENTILATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 45 VENTILATORS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 46 VENTILATORS MARKET, BY REGION, 2023-2030 (THOUSAND UNITS)
  • TABLE 47 MAJOR PLAYERS OFFERING ICU VENTILATORS
  • TABLE 48 ICU VENTILATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 49 ICU VENTILATORS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 50 HIGH-END VENTILATORS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 51 MID-END VENTILATORS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 52 BASIC VENTILATORS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 53 MAJOR PLAYERS OFFERING PORTABLE/TRANSPORTABLE VENTILATORS
  • TABLE 54 PORTABLE/TRANSPORTABLE VENTILATORS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 55 MAJOR PLAYERS OFFERING NEBULIZERS
  • TABLE 56 NEBULIZERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 57 NEBULIZERS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 58 NEBULIZERS MARKET, BY REGION, 2023-2030 (THOUSAND UNITS)
  • TABLE 59 JET NEBULIZERS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 60 MESH NEBULIZERS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 61 ULTRASONIC NEBULIZERS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 62 HUMIDIFIERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 63 HUMIDIFIERS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 64 MAJOR PLAYERS OFFERING HEATED HUMIDIFIERS
  • TABLE 65 HEATED HUMIDIFIERS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 66 MAJOR PLAYERS OFFERING PASSOVER HUMIDIFIERS
  • TABLE 67 PASSOVER HUMIDIFIERS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 68 MAJOR PLAYERS OFFERING OXYGEN CONCENTRATORS
  • TABLE 69 OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 70 OXYGEN CONCENTRATORS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 71 FIXED OXYGEN CONCENTRATORS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 72 PORTABLE OXYGEN CONCENTRATORS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 73 INHALERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 74 INHALERS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 75 METERED-DOSE INHALERS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 76 DRY POWDER INHALERS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 77 MAJOR PLAYERS OFFERING REUSABLE RESUSCITATORS
  • TABLE 78 REUSABLE RESUSCITATORS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 79 MAJOR PLAYERS OFFERING NITRIC OXIDE DELIVERY UNITS
  • TABLE 80 NITRIC OXIDE DELIVERY UNITS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 81 MAJOR PLAYERS OFFERING OXYGEN HOODS
  • TABLE 82 OXYGEN HOODS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 83 RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 84 RESPIRATORY CARE MONITORING DEVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 85 MAJOR PLAYERS OFFERING PULSE OXIMETERS
  • TABLE 86 PULSE OXIMETERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 87 PULSE OXIMETERS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 88 PULSE OXIMETER SENSORS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 89 MAJOR PLAYERS OFFERING PULSE OXIMETER EQUIPMENT
  • TABLE 90 PULSE OXIMETER EQUIPMENT MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 91 MAJOR PLAYERS OFFERING CAPNOGRAPHS
  • TABLE 92 CAPNOGRAPHS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 93 MAJOR PLAYERS OFFERING GAS ANALYZERS
  • TABLE 94 GAS ANALYZERS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 95 DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 96 DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 97 MAJOR PLAYERS OFFERING SPIROMETERS
  • TABLE 98 SPIROMETERS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 99 SPIROMETERS MARKET, BY REGION, 2023-2030 (THOUSAND UNITS)
  • TABLE 100 MAJOR PLAYERS OFFERING POLYSOMNOGRAPHY DEVICES
  • TABLE 101 POLYSOMNOGRAPHY DEVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 102 MAJOR PLAYERS OFFERING PEAK FLOW METERS
  • TABLE 103 PEAK FLOW METERS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 104 OTHER DIAGNOSTIC DEVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 105 RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 106 RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 107 MASKS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 108 MASKS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 109 REUSABLE MASKS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 110 DISPOSABLE MASKS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 111 DISPOSABLE RESUSCITATORS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 112 TRACHEOSTOMY TUBES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 113 BREATHING CIRCUITS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 114 NASAL CANNULAE MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 115 OTHER CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 116 RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2023-2030 (USD MILLION)
  • TABLE 117 DISEASE INDICATION: RESPIRATORY CARE DEVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 118 RESPIRATORY CARE DEVICES MARKET FOR COPD, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 119 COUNTRY-WISE DATA ON SLEEP APNEA PATIENTS
  • TABLE 120 RESPIRATORY CARE DEVICES MARKET FOR SLEEP APNEA, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 121 RESPIRATORY CARE DEVICES MARKET FOR ASTHMA, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 122 INCIDENCE OF TB (RATE PER 100,000 POPULATION)
  • TABLE 123 RESPIRATORY CARE DEVICES MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 124 RESPIRATORY CARE DEVICES MARKET FOR OTHER DISEASE INDICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 125 RESPIRATORY CARE DEVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 126 END USER: RESPIRATORY CARE DEVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 127 RESPIRATORY CARE DEVICES MARKET FOR HOSPITALS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 128 RESPIRATORY CARE DEVICES MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 129 RESPIRATORY CARE DEVICES MARKET FOR AMBULATORY CARE CENTERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 130 RESPIRATORY CARE DEVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 131 RESPIRATORY CARE DEVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 132 NORTH AMERICA: RESPIRATORY CARE DEVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 133 NORTH AMERICA: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 134 NORTH AMERICA: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 135 NORTH AMERICA: PAP DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 136 NORTH AMERICA: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 137 NORTH AMERICA: VENTILATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 138 NORTH AMERICA: ICU VENTILATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 139 NORTH AMERICA: INHALERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 140 NORTH AMERICA: HUMIDIFIERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 141 NORTH AMERICA: NEBULIZERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 142 NORTH AMERICA: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 143 NORTH AMERICA: PULSE OXIMETERS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 144 NORTH AMERICA: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 145 NORTH AMERICA: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 146 NORTH AMERICA: MASKS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 147 NORTH AMERICA: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2023-2030 (USD MILLION)
  • TABLE 148 NORTH AMERICA: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 149 US: KEY MACROINDICATORS
  • TABLE 150 US: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 151 US: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 152 US: PAP DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 153 US: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 154 US: VENTILATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 155 US: ICU VENTILATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 156 US: INHALERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 157 US: HUMIDIFIERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 158 US: NEBULIZERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 159 US: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 160 US: PULSE OXIMETERS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 161 US: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 162 US: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 163 US: MASKS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 164 US: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2023-2030 (USD MILLION)
  • TABLE 165 US: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 166 CANADA: COPD AND ASTHMA STATISTICS (2019 VS. 2020)
  • TABLE 167 CANADA: KEY MACROINDICATORS
  • TABLE 168 CANADA: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 169 CANADA: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 170 CANADA: PAP DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 171 CANADA: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 172 CANADA: VENTILATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 173 CANADA: ICU VENTILATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 174 CANADA: INHALERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 175 CANADA: HUMIDIFIERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 176 CANADA: NEBULIZERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 177 CANADA: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 178 CANADA: PULSE OXIMETERS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 179 CANADA: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 180 CANADA: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 181 CANADA: MASKS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 182 CANADA: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2023-2030 (USD MILLION)
  • TABLE 183 CANADA: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 184 EUROPE: RESPIRATORY CARE DEVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 185 EUROPE: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 186 EUROPE: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 187 EUROPE: PAP DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 188 EUROPE: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 189 EUROPE: VENTILATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 190 EUROPE: ICU VENTILATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 191 EUROPE: INHALERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 192 EUROPE: HUMIDIFIERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 193 EUROPE: NEBULIZERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 194 EUROPE: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 195 EUROPE: PULSE OXIMETERS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 196 EUROPE: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 197 EUROPE: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 198 EUROPE: MASKS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 199 EUROPE: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2023-2030 (USD MILLION)
  • TABLE 200 EUROPE: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 201 GERMANY: KEY MACROINDICATORS
  • TABLE 202 GERMANY: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 203 GERMANY: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 204 GERMANY: PAP DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 205 GERMANY: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 206 GERMANY: VENTILATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 207 GERMANY: ICU VENTILATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 208 GERMANY: INHALERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 209 GERMANY: HUMIDIFIERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 210 GERMANY: NEBULIZERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 211 GERMANY: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 212 GERMANY: PULSE OXIMETERS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 213 GERMANY: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 214 GERMANY: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 215 GERMANY: MASKS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 216 GERMANY: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2023-2030 (USD MILLION)
  • TABLE 217 GERMANY: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 218 FRANCE: KEY MACROINDICATORS
  • TABLE 219 FRANCE: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 220 FRANCE: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 221 FRANCE: PAP DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 222 FRANCE: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 223 FRANCE: VENTILATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 224 FRANCE: ICU VENTILATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 225 FRANCE: INHALERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 226 FRANCE: HUMIDIFIERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 227 FRANCE: NEBULIZERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 228 FRANCE: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 229 FRANCE: PULSE OXIMETERS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 230 FRANCE: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 231 FRANCE: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 232 FRANCE: MASKS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 233 FRANCE: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2023-2030 (USD MILLION)
  • TABLE 234 FRANCE: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 235 UK: KEY MACROINDICATORS
  • TABLE 236 UK: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 237 UK: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 238 UK: PAP DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 239 UK: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 240 UK: VENTILATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 241 UK: ICU VENTILATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 242 UK: INHALERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 243 UK: HUMIDIFIERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 244 UK: NEBULIZERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 245 UK: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 246 UK: PULSE OXIMETERS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 247 UK: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 248 UK: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 249 UK: MASKS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 250 UK: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2023-2030 (USD MILLION)
  • TABLE 251 UK: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 252 ITALY: KEY MACROINDICATORS
  • TABLE 253 ITALY: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 254 ITALY: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 255 ITALY: PAP DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 256 ITALY: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 257 ITALY: VENTILATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 258 ITALY: ICU VENTILATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 259 ITALY: INHALERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 260 ITALY: HUMIDIFIERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 261 ITALY: NEBULIZERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 262 ITALY: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 263 ITALY: PULSE OXIMETERS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 264 ITALY: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 265 ITALY: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 266 ITALY: MASKS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 267 ITALY: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2023-2030 (USD MILLION)
  • TABLE 268 ITALY: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 269 SPAIN: KEY MACROINDICATORS
  • TABLE 270 SPAIN: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 271 SPAIN: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 272 SPAIN: PAP DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 273 SPAIN: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 274 SPAIN: VENTILATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 275 SPAIN: ICU VENTILATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 276 SPAIN: INHALERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 277 SPAIN: HUMIDIFIERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 278 SPAIN: NEBULIZERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 279 SPAIN: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 280 SPAIN: PULSE OXIMETERS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 281 SPAIN: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 282 SPAIN: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 283 SPAIN: MASKS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 284 SPAIN: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2023-2030 (USD MILLION)
  • TABLE 285 SPAIN: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 286 REST OF EUROPE: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 287 REST OF EUROPE: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 288 REST OF EUROPE: PAP DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 289 REST OF EUROPE: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 290 REST OF EUROPE: VENTILATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 291 REST OF EUROPE: ICU VENTILATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 292 REST OF EUROPE: INHALERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 293 REST OF EUROPE: HUMIDIFIERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 294 REST OF EUROPE: NEBULIZERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 295 REST OF EUROPE: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 296 REST OF EUROPE: PULSE OXIMETERS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 297 REST OF EUROPE: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 298 REST OF EUROPE: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 299 REST OF EUROPE: MASKS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 300 REST OF EUROPE: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2023-2030 (USD MILLION)
  • TABLE 301 REST OF EUROPE: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 302 ASIA PACIFIC: RESPIRATORY CARE DEVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 303 ASIA PACIFIC: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 304 ASIA PACIFIC: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 305 ASIA PACIFIC: PAP DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 306 ASIA PACIFIC: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 307 ASIA PACIFIC: VENTILATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 308 ASIA PACIFIC: ICU VENTILATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 309 ASIA PACIFIC: INHALERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 310 ASIA PACIFIC: HUMIDIFIERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 311 ASIA PACIFIC: NEBULIZERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 312 ASIA PACIFIC: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 313 ASIA PACIFIC: PULSE OXIMETERS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 314 ASIA PACIFIC: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 315 ASIA PACIFIC: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 316 ASIA PACIFIC: MASKS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 317 ASIA PACIFIC: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2023-2030 (USD MILLION)
  • TABLE 318 ASIA PACIFIC: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 319 JAPAN: KEY MACROINDICATORS
  • TABLE 320 JAPAN: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 321 JAPAN: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 322 JAPAN: PAP DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 323 JAPAN: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 324 JAPAN: VENTILATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 325 JAPAN: ICU VENTILATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 326 JAPAN: INHALERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 327 JAPAN: HUMIDIFIERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 328 JAPAN: NEBULIZERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 329 JAPAN: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 330 JAPAN: PULSE OXIMETERS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 331 JAPAN: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 332 JAPAN: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 333 JAPAN: MASKS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 334 JAPAN: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2023-2030 (USD MILLION)
  • TABLE 335 JAPAN: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 336 CHINA: KEY MACROINDICATORS
  • TABLE 337 CHINA: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 338 CHINA: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 339 CHINA: PAP DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 340 CHINA: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 341 CHINA: VENTILATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 342 CHINA: ICU VENTILATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 343 CHINA: INHALERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 344 CHINA: HUMIDIFIERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 345 CHINA: NEBULIZERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 346 CHINA: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 347 CHINA: PULSE OXIMETERS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 348 CHINA: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 349 CHINA: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 350 CHINA: MASKS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 351 CHINA: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2023-2030 (USD MILLION)
  • TABLE 352 CHINA: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 353 INDIA: KEY MACROINDICATORS
  • TABLE 354 INDIA: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 355 INDIA: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 356 INDIA: PAP DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 357 INDIA: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 358 INDIA: VENTILATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 359 INDIA: ICU VENTILATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 360 INDIA: INHALERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 361 INDIA: HUMIDIFIERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 362 INDIA: NEBULIZERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 363 INDIA: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 364 INDIA: PULSE OXIMETERS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 365 INDIA: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 366 INDIA: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 367 INDIA: MASKS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 368 INDIA: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2023-2030 (USD MILLION)
  • TABLE 369 INDIA: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 370 AUSTRALIA: KEY MACROINDICATORS
  • TABLE 371 AUSTRALIA: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 372 AUSTRALIA: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 373 AUSTRALIA: PAP DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 374 AUSTRALIA: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 375 AUSTRALIA: VENTILATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 376 AUSTRALIA: ICU VENTILATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 377 AUSTRALIA: INHALERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 378 AUSTRALIA: HUMIDIFIERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 379 AUSTRALIA: NEBULIZERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 380 AUSTRALIA: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 381 AUSTRALIA: PULSE OXIMETERS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 382 AUSTRALIA: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 383 AUSTRALIA: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 384 AUSTRALIA: MASKS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 385 AUSTRALIA: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2023-2030 (USD MILLION)
  • TABLE 386 AUSTRALIA: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 387 SOUTH KOREA: KEY MACROINDICATORS
  • TABLE 388 SOUTH KOREA: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 389 SOUTH KOREA: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 390 SOUTH KOREA: PAP DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 391 SOUTH KOREA: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 392 SOUTH KOREA: VENTILATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 393 SOUTH KOREA: ICU VENTILATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 394 SOUTH KOREA: INHALERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 395 SOUTH KOREA: HUMIDIFIERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 396 SOUTH KOREA: NEBULIZERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 397 SOUTH KOREA: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 398 SOUTH KOREA: PULSE OXIMETERS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 399 SOUTH KOREA: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 400 SOUTH KOREA: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 401 SOUTH KOREA: MASKS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 402 SOUTH KOREA: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2023-2030 (USD MILLION)
  • TABLE 403 SOUTH KOREA: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 404 REST OF ASIA PACIFIC: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 405 REST OF ASIA PACIFIC: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 406 REST OF ASIA PACIFIC: PAP DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 407 REST OF ASIA PACIFIC: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 408 REST OF ASIA PACIFIC: VENTILATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 409 REST OF ASIA PACIFIC: ICU VENTILATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 410 REST OF ASIA PACIFIC: INHALERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 411 REST OF ASIA PACIFIC: HUMIDIFIERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 412 REST OF ASIA PACIFIC: NEBULIZERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 413 REST OF ASIA PACIFIC: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 414 REST OF ASIA PACIFIC: PULSE OXIMETERS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 415 REST OF ASIA PACIFIC: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 416 REST OF ASIA PACIFIC: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 417 REST OF ASIA PACIFIC: MASKS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 418 REST OF ASIA PACIFIC: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2023-2030 (USD MILLION)
  • TABLE 419 REST OF ASIA PACIFIC: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 420 LATIN AMERICA: RESPIRATORY CARE DEVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 421 LATIN AMERICA: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 422 LATIN AMERICA: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 423 LATIN AMERICA: PAP DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 424 LATIN AMERICA: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 425 LATIN AMERICA: VENTILATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 426 LATIN AMERICA: ICU VENTILATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 427 LATIN AMERICA: INHALERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 428 LATIN AMERICA: HUMIDIFIERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 429 LATIN AMERICA: NEBULIZERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 430 LATIN AMERICA: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 431 LATIN AMERICA: PULSE OXIMETERS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 432 LATIN AMERICA: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 433 LATIN AMERICA: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 434 LATIN AMERICA: MASKS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 435 LATIN AMERICA: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2023-2030 (USD MILLION)
  • TABLE 436 LATIN AMERICA: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 437 BRAZIL: KEY MACROINDICATORS
  • TABLE 438 BRAZIL: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 439 BRAZIL: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 440 BRAZIL: PAP DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 441 BRAZIL: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 442 BRAZIL: VENTILATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 443 BRAZIL: ICU VENTILATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 444 BRAZIL: INHALERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 445 BRAZIL: HUMIDIFIERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 446 BRAZIL: NEBULIZERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 447 BRAZIL: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 448 BRAZIL: PULSE OXIMETERS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 449 BRAZIL: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 450 BRAZIL: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 451 BRAZIL: MASKS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 452 BRAZIL: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2023-2030 (USD MILLION)
  • TABLE 453 BRAZIL: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 454 MEXICO: KEY MACROINDICATORS
  • TABLE 455 MEXICO: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 456 MEXICO: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 457 MEXICO: PAP DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 458 MEXICO: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 459 MEXICO: VENTILATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 460 MEXICO: ICU VENTILATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 461 MEXICO: INHALERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 462 MEXICO: HUMIDIFIERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 463 MEXICO: NEBULIZERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 464 MEXICO: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 465 MEXICO: PULSE OXIMETERS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 466 MEXICO: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 467 MEXICO: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 468 MEXICO: MASKS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 469 MEXICO: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2023-2030 (USD MILLION)
  • TABLE 470 MEXICO: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 471 REST OF LATIN AMERICA: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 472 REST OF LATIN AMERICA: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 473 REST OF LATIN AMERICA: PAP DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 474 REST OF LATIN AMERICA: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 475 REST OF LATIN AMERICA: VENTILATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 476 REST OF LATIN AMERICA: ICU VENTILATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 477 REST OF LATIN AMERICA: INHALERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 478 REST OF LATIN AMERICA: HUMIDIFIERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 479 REST OF LATIN AMERICA: NEBULIZERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 480 REST OF LATIN AMERICA: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 481 REST OF LATIN AMERICA: PULSE OXIMETERS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 482 REST OF LATIN AMERICA: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 483 REST OF LATIN AMERICA: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 484 REST OF LATIN AMERICA: MASKS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 485 REST OF LATIN AMERICA: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2023-2030 (USD MILLION)
  • TABLE 486 REST OF LATIN AMERICA: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 487 MIDDLE EAST & AFRICA: RESPIRATORY CARE DEVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 488 MIDDLE EAST & AFRICA: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 489 MIDDLE EAST & AFRICA: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 490 MIDDLE EAST & AFRICA: PAP DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 491 MIDDLE EAST & AFRICA: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 492 MIDDLE EAST & AFRICA: VENTILATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 493 MIDDLE EAST & AFRICA: ICU VENTILATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 494 MIDDLE EAST & AFRICA: INHALERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 495 MIDDLE EAST & AFRICA: HUMIDIFIERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 496 MIDDLE EAST & AFRICA: NEBULIZERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 497 MIDDLE EAST & AFRICA: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 498 MIDDLE EAST & AFRICA: PULSE OXIMETERS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 499 MIDDLE EAST & AFRICA: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 500 MIDDLE EAST & AFRICA: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 501 MIDDLE EAST & AFRICA: MASKS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 502 MIDDLE EAST & AFRICA: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2023-2030 (USD MILLION)
  • TABLE 503 MIDDLE EAST & AFRICA: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 504 GCC COUNTRIES: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 505 GCC COUNTRIES: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 506 GCC COUNTRIES: PAP DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 507 GCC COUNTRIES: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 508 GCC COUNTRIES: VENTILATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 509 GCC COUNTRIES: ICU VENTILATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 510 GCC COUNTRIES: INHALERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 511 GCC COUNTRIES: HUMIDIFIERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 512 GCC COUNTRIES: NEBULIZERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 513 GCC COUNTRIES: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 514 GCC COUNTRIES: PULSE OXIMETERS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 515 GCC COUNTRIES: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 516 GCC COUNTRIES: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 517 GCC COUNTRIES: MASKS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 518 GCC COUNTRIES: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2023-2030 (USD MILLION)
  • TABLE 519 GCC COUNTRIES: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 520 REST OF MIDDLE EAST & AFRICA: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 521 REST OF MIDDLE EAST & AFRICA: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 522 REST OF MIDDLE EAST & AFRICA: PAP DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 523 REST OF MIDDLE EAST & AFRICA: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 524 REST OF MIDDLE EAST & AFRICA: VENTILATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 525 REST OF MIDDLE EAST & AFRICA: ICU VENTILATORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 526 REST OF MIDDLE EAST & AFRICA: INHALERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 527 REST OF MIDDLE EAST & AFRICA: HUMIDIFIERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 528 REST OF MIDDLE EAST & AFRICA: NEBULIZERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 529 REST OF MIDDLE EAST & AFRICA: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 530 REST OF MIDDLE EAST & AFRICA: PULSE OXIMETERS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
  • TABLE 531 REST OF MIDDLE EAST & AFRICA: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 532 REST OF MIDDLE EAST & AFRICA: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 533 REST OF MIDDLE EAST & AFRICA: MASKS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 534 REST OF MIDDLE EAST & AFRICA: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2023-2030 (USD MILLION)
  • TABLE 535 REST OF MIDDLE EAST & AFRICA: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 536 STRATEGIES ADOPTED BY KEY PLAYERS IN RESPIRATORY CARE DEVICES MARKET, JANUARY 2021-APRIL 2025
  • TABLE 537 RESPIRATORY CARE DEVICES MARKET: DEGREE OF COMPETITION
  • TABLE 538 RESPIRATORY CARE DEVICES MARKET: REGION FOOTPRINT
  • TABLE 539 RESPIRATORY CARE DEVICES MARKET: PRODUCT TYPE FOOTPRINT
  • TABLE 540 RESPIRATORY CARE DEVICES MARKET: DISEASE INDICATION FOOTPRINT
  • TABLE 541 RESPIRATORY CARE DEVICES MARKET: END USER FOOTPRINT
  • TABLE 542 RESPIRATORY CARE DEVICES MARKET: DETAILED LIST OF KEY STARTUPS/SMES
  • TABLE 543 RESPIRATORY CARE DEVICES MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
  • TABLE 544 RESPIRATORY CARE DEVICES MARKET: PRODUCT & SERVICE LAUNCHES AND APPROVALS, JANUARY 2021-APRIL 2025
  • TABLE 545 RESPIRATORY CARE DEVICES MARKET: DEALS, JANUARY 2021-APRIL 2025
  • TABLE 546 RESPIRATORY CARE DEVICES MARKET: EXPANSIONS, JANUARY 2021-APRIL 2025
  • TABLE 547 RESPIRATORY CARE DEVICES MARKET: OTHER DEVELOPMENTS, JANUARY 2021- APRIL 2025
  • TABLE 548 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW
  • TABLE 549 KONINKLIJKE PHILIPS N.V.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-APRIL 2025
  • TABLE 550 MEDTRONIC: COMPANY OVERVIEW
  • TABLE 551 MEDTRONIC PLC: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-APRIL 2025
  • TABLE 552 MEDTRONIC PLC: OTHER DEVELOPMENTS, JANUARY 2021-APRIL 2025
  • TABLE 553 RESMED INC.: COMPANY OVERVIEW
  • TABLE 554 RESMED INC: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-APRIL 2025
  • TABLE 555 RESMED INC: DEALS, JANUARY 2021-APRIL 2025
  • TABLE 556 FISHER & PAYKEL HEALTHCARE LIMITED: COMPANY OVERVIEW
  • TABLE 557 FISHER & PAYKEL HEALTHCARE LIMITED: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-APRIL 2025
  • TABLE 558 DRAGERWERK AG & CO. KGAA: COMPANY OVERVIEW
  • TABLE 559 DRAGERWERK AG & CO. KGAA: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-APRIL 2025
  • TABLE 560 DRAGERWERK AG & CO. KGAA: DEALS, JANUARY 2021-APRIL 2025
  • TABLE 561 DRAGERWERK AG & CO. KGAA: OTHER DEVELOPMENTS, JANUARY 2021-APRIL 2025
  • TABLE 562 MASIMO: COMPANY OVERVIEW
  • TABLE 563 MASIMO: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-APRIL 2025
  • TABLE 564 MASIMO: DEALS, JANUARY 2021-APRIL 2025
  • TABLE 565 MASIMO: OTHER DEVELOPMENTS, JANUARY 2021-APRIL 2025
  • TABLE 566 GETINGE: COMPANY OVERVIEW
  • TABLE 567 GETINGE: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-APRIL 2025
  • TABLE 568 GETINGE: DEALS, JANUARY 2021-APRIL 2025
  • TABLE 569 GETINGE: EXPANSIONS, JANUARY 2021-APRIL 2025
  • TABLE 570 NIHON KOHDEN CORPORATION: COMPANY OVERVIEW
  • TABLE 571 NIHON KOHDEN CORPORATION: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-APRIL 2025
  • TABLE 572 NIHON KOHDEN CORPORATION: DEALS, JANUARY 2021-APRIL 2025
  • TABLE 573 GE HEALTHCARE: COMPANY OVERVIEW
  • TABLE 574 GE HEALTHCARE: DEALS, JANUARY 2021-APRIL 2025
  • TABLE 575 GE HEALTHCARE: OTHER DEVELOPMENTS, JANUARY 2021-MARCH 2025
  • TABLE 576 HILLROM & WELCH ALLYN (BAXTER): COMPANY OVERVIEW
  • TABLE 577 HILLROM & WELCH ALLYN (BAXTER): PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-MARCH 2024
  • TABLE 578 HILLROM & WELCH ALLYN (BAXTER): DEALS, JANUARY 2021-MARCH 2024
  • TABLE 579 ADAPTHEALTH, LLC: COMPANY OVERVIEW
  • TABLE 580 TELEFLEX INCORPORATED: COMPANY OVERVIEW
  • TABLE 581 AIR LIQUIDE: COMPANY OVERVIEW
  • TABLE 582 AIR LIQUIDE: DEALS, JANUARY 2021-APRIL 2025
  • TABLE 583 ICU MEDICAL, INC.: COMPANY OVERVIEW
  • TABLE 584 ICU MEDICAL, INC.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-APRIL 2025
  • TABLE 585 ICU MEDICAL, INC.: DEALS, JANUARY 2021-MARCH 2024
  • TABLE 586 HAMILTON MEDICAL: COMPANY OVERVIEW
  • TABLE 587 HAMILTON MEDICAL: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-MARCH 2024

List of Figures

  • FIGURE 1 RESPIRATORY CARE DEVICES MARKET SEGMENTATION
  • FIGURE 2 RESEARCH DESIGN
  • FIGURE 3 PRIMARY SOURCES
  • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
  • FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE), BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE), BY END USER, DESIGNATION, AND REGION
  • FIGURE 7 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
  • FIGURE 8 REVENUE SHARE ANALYSIS ILLUSTRATION: RESMED INC.
  • FIGURE 9 SUPPLY-SIDE MARKET ESTIMATION: RESPIRATORY CARE DEVICES MARKET (2024)
  • FIGURE 10 DEMAND-SIDE MARKET ESTIMATION: RESPIRATORY CARE DEVICES MARKET (2024)
  • FIGURE 11 TOTAL MARKET SIZE ESTIMATION: RESPIRATORY CARE DEVICES MARKET
  • FIGURE 12 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2025-2030)
  • FIGURE 13 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
  • FIGURE 14 TOP-DOWN APPROACH
  • FIGURE 15 MARKET DATA TRIANGULATION METHODOLOGY
  • FIGURE 16 RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2025 VS. 2030 (USD MILLION)
  • FIGURE 17 RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2025 VS. 2030 (USD MILLION)
  • FIGURE 18 RESPIRATORY CARE DEVICES MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
  • FIGURE 19 GEOGRAPHIC SNAPSHOT: RESPIRATORY CARE DEVICES MARKET
  • FIGURE 20 RISING PREVALENCE OF RESPIRATORY DISEASES TO DRIVE MARKET GROWTH DURING FORECAST PERIOD
  • FIGURE 21 INDIA ACCOUNTED FOR LARGEST SHARE OF RESPIRATORY CARE DEVICES MARKET IN ASIA PACIFIC IN 2024
  • FIGURE 22 INDIA TO GROW AT HIGHEST RATE DURING FORECAST PERIOD
  • FIGURE 23 NORTH AMERICA WILL CONTINUE TO DOMINATE RESPIRATORY CARE DEVICES MARKET DURING FORECAST PERIOD
  • FIGURE 24 DEVELOPING MARKETS TO REGISTER FASTEST GROWTH DURING FORECAST PERIOD
  • FIGURE 25 RESPIRATORY CARE DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 26 GLOBAL GERIATRIC POPULATION, BY REGION
  • FIGURE 27 ANNUAL DATA OF DEATHS CAUSED BY HOUSEHOLD AND AMBIENT AIR POLLUTION, BY DISEASE
  • FIGURE 28 IMPACT OF INNOVATIVE SOLUTIONS
  • FIGURE 29 INTRODUCTION OF INNOVATIVE SOLUTIONS FOR SLEEP APNEA TREATMENT
  • FIGURE 30 VALUE CHAIN ANALYSIS
  • FIGURE 31 SUPPLY CHAIN ANALYSIS
  • FIGURE 32 ADJACENT MARKETS FOR RESPIRATORY CARE DEVICES MARKET
  • FIGURE 33 TOP PATENT APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR RESPIRATORY CARE DEVICES MARKET
  • FIGURE 34 TOP PATENT APPLICANT COUNTRIES FOR RESPIRATORY CARE DEVICES (JANUARY 2014-DECEMBER 2024)
  • FIGURE 35 RESPIRATORY CARE DEVICES MARKET: ECOSYSTEM MARKET MAP
  • FIGURE 36 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES IN RESPIRATORY CARE DEVICES MARKET
  • FIGURE 37 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR RESPIRATORY CARE DEVICES
  • FIGURE 38 KEY BUYING CRITERIA FOR RESPIRATORY CARE DEVICES
  • FIGURE 39 RESPIRATORY CARE DEVICES MARKET: REGIONAL GROWTH OPPORTUNITIES
  • FIGURE 40 NORTH AMERICA: RESPIRATORY CARE DEVICES MARKET SNAPSHOT
  • FIGURE 41 ASIA PACIFIC: RESPIRATORY CARE DEVICES MARKET SNAPSHOT
  • FIGURE 42 REVENUE SHARE ANALYSIS OF KEY PLAYERS IN RESPIRATORY CARE DEVICES MARKET (2020-2024)
  • FIGURE 43 RESPIRATORY CARE DEVICES MARKET SHARE ANALYSIS, BY KEY PLAYER (2024)
  • FIGURE 44 RESPIRATORY CARE DEVICES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
  • FIGURE 45 RESPIRATORY CARE DEVICES MARKET: COMPANY FOOTPRINT
  • FIGURE 46 RESPIRATORY CARE DEVICES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
  • FIGURE 47 EV/EBITDA OF KEY VENDORS
  • FIGURE 48 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 49 RESPIRATORY CARE DEVICES MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
  • FIGURE 50 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2024)
  • FIGURE 51 MEDTRONIC: COMPANY SNAPSHOT (2024)
  • FIGURE 52 RESMED INC.: COMPANY SNAPSHOT (2024)
  • FIGURE 53 FISHER & PAYKEL HEALTHCARE LIMITED: COMPANY SNAPSHOT (2024)
  • FIGURE 54 DRAGERWERK AG & CO. KGAA: COMPANY SNAPSHOT (2024)
  • FIGURE 55 MASIMO: COMPANY SNAPSHOT (2024)
  • FIGURE 56 GETINGE: COMPANY SNAPSHOT (2024)
  • FIGURE 57 NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT (2023)
  • FIGURE 58 GE HEALTHCARE: COMPANY SNAPSHOT (2024)
  • FIGURE 59 HILLROM & WELCH ALLYN (BAXTER): COMPANY SNAPSHOT (2024)
  • FIGURE 60 ADAPTHEALTH, LLC: COMPANY SNAPSHOT (2024)
  • FIGURE 61 TELEFLEX INCORPORATED: COMPANY SNAPSHOT (2024)
  • FIGURE 62 AIR LIQUIDE: COMPANY SNAPSHOT (2024)
  • FIGURE 63 ICU MEDICAL, INC.: COMPANY SNAPSHOT (2024)